Parameswaran Venugopal to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Parameswaran Venugopal has written about Drug Resistance, Neoplasm.
Connection Strength
0.126
-
Efficacy and safety of clofarabine in relapsed and/or refractory non-Hodgkin lymphoma, including rituximab-refractory patients. Cancer. 2011 Apr 01; 117(7):1490-7.
Score: 0.086
-
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma. Invest New Drugs. 2020 10; 38(5):1448-1453.
Score: 0.041